BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6160367)

  • 41. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 42. Involvement of brain monoamines in the stimulant and paradoxical inhibitory effects of methylphenidate.
    Breese GR; Cooper BR; Hollister AS
    Psychopharmacologia; 1975 Oct; 44(1):5-10. PubMed ID: 128026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sleep in the rate following raphe lesion: pharmacology of the serotonin system].
    Adrien J; Laguzzi R; Bourgoin S; Hamon M
    Waking Sleeping; 1980; 4(2):119-29. PubMed ID: 6447408
    [No Abstract]   [Full Text] [Related]  

  • 44. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
    Eide PK; Hole K; Berge OG; Broch OJ
    Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative effects of various serotonin releasing agents in mice.
    Hwang EC; Van Woert MH
    Biochem Pharmacol; 1980 Dec; 29(23):3163-7. PubMed ID: 6449931
    [No Abstract]   [Full Text] [Related]  

  • 46. A quantitative rotational model for studying serotonergic function in the rat.
    Jacobs BL; Simon SM; Ruimy DD; Trulson ME
    Brain Res; 1977 Mar; 124(2):271-81. PubMed ID: 139194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropharmacological regulation of mouse killing by rats.
    Barr GA; Bridger WH; Gibbons JL
    Behav Biol; 1976 Jun; 17(2):143-59. PubMed ID: 134689
    [No Abstract]   [Full Text] [Related]  

  • 48. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
    Pranzatelli MR; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
    Dewar KM; Grondin L; Carli M; Lima L; Reader TA
    J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats.
    Ortmann R; Waldmeier PC; Radeke E; Felner A; Delini-Stula A
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Mar; 311(2):185-92. PubMed ID: 6966764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central serotonin involvement in the elaboration of the startle reaction in rats.
    Fechter LD
    Pharmacol Biochem Behav; 1974; 2(2):161-71. PubMed ID: 4275271
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of palmatine on motor activity and the concentration of central monoamines and its metabolites in rats.
    Hsieh MT; Su SH; Tsai HY; Peng WH; Hsieh CC; Chen CF
    Jpn J Pharmacol; 1993 Jan; 61(1):1-5. PubMed ID: 7679763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5.7-dihydroxytryptamine injection.
    Barbeau H; Bédard P
    Neuropharmacology; 1981 May; 20(5):477-81. PubMed ID: 6165921
    [No Abstract]   [Full Text] [Related]  

  • 55. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia.
    Chance WT; von Meyenfeldt M; Fischer JE
    Pharmacol Biochem Behav; 1983 Jan; 18(1):115-21. PubMed ID: 6187026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fenfluramine-induced enhancement of confinement motor activity: an indirect 5-hydroxytryptamine-like action?
    Clineschmidt BV; McGuffin JC; Pflueger AB; Totaro JA
    Neuropharmacology; 1975 Apr; 14(4):301-11. PubMed ID: 124023
    [No Abstract]   [Full Text] [Related]  

  • 57. MK-801 protects against amphetamine-induced striatal dopamine depletion in iprindole-treated rats, but not against brain serotonin depletion after p-chloroamphetamine administration.
    Henderson MG; Hemrick-Luecke S; Fuller RW
    Ann N Y Acad Sci; 1992 May; 648():286-8. PubMed ID: 1379012
    [No Abstract]   [Full Text] [Related]  

  • 58. Evidence that serotonergic neurons in the dorsal raphe nucleus exert a stimulatory effect on the secretion of renin but not of corticosterone.
    Van de Kar LD; Wilkinson CW; Skrobik Y; Brownfield MS; Ganong WF
    Brain Res; 1982 Mar; 235(2):233-43. PubMed ID: 6765221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term effects of 4-chloroamphetamine on brain 5-hydroxyindole metabolism in rats.
    Fuller RW; Snoddy HD
    Neuropharmacology; 1974 Jan; 13(1):85-90. PubMed ID: 4823689
    [No Abstract]   [Full Text] [Related]  

  • 60. Selective decrease in protein intake following brain serotonin depletion.
    Ashley DV; Coscina DV; Anderson GH
    Life Sci; 1979 Mar; 24(11):973-84. PubMed ID: 156297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.